OPI One Step Opiates Rapid Test (Oral Fluid)
Rapid lateral flow immunoassay for the qualitative detection of opiates in oral fluid, used by healthcare professionals to screen for recent opioid exposure. CE Marked.
Product Description
This is a competitive binding immunoassay presented as a lateral flow device. A solid-phase membrane carries opiate antibody and the matching drug-protein conjugate, with the antibody coupled to colloidal gold. Applied oral fluid migrates by capillary action and any opiate present competes with the conjugate for limited antibody binding sites. When enough drug is present it saturates the antibody, the conjugate is not captured at the test line, and the test line disappears — a missing test line is read as positive. In a negative sample a visible test line forms. A colored control line must appear in every valid run, confirming adequate specimen and proper membrane wicking.
Opiates such as heroin, morphine and codeine are derived from the resin of the opium poppy. Heroin is rapidly converted to morphine in the body, and codeine is also transformed to morphine, so the presence of morphine or its glucuronide in saliva often points to use of heroin, morphine or codeine, with a risk of respiratory depression and dependence. Oral fluid testing indicates recent exposure, but interpretation should consider legitimate medication and clinical history. The test is a preliminary qualitative screen only; it does not measure concentration, timing or impairment. Presumptive positives require laboratory confirmation, and a physician should make the final diagnosis.
Specifications
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| OPI Opiates | OPI-R02 | Oral Fluid | 40ng/ml | Device |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the OPI One Step Opiates Rapid Test (Oral Fluid).